why choose us

First received: November 10, 2023

Clinical Trial: A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Renal Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: Phase 1b Study of the Safety of Concurrent Cabozantinib and Nivolumab With Radiation Therapy for Brain Metastases in Patients With Metastatic Renal Cell Carcinoma

Brief Summary: The purpose of this study is to find out whether the combination of cabozantinib, nivolumab, and radiation therapy is a safe and effective treatment that causes few or mild side effects in people with renal cell cancer that has spread to the brain.The researches will also look at how the study treatment affects the quality of life of participants.They will measure the quality of life by having participants complete questionnaires.

Read more